Adma Biologics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Ramsey, NJ
ADMA chart
What traders are saying about $ADMA
Latest postsAdma Biologics, Inc. news
- ADMA Biologics (ADMA) Could Be 2% Below Fair Value After Q3 Growth
Simply Wall St ·
- What ADMA Biologics (ADMA)'s Strong Earnings Report Means For Shareholders
Simply Wall St ·
- Top 3 Healthcare Stocks To Watch In November 2026
Yahoo Finance ·
- Results: ADMA Biologics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Simply Wall St ·
- ADMA Biologics, Inc. (ADMA) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average
Yahoo Finance ·
- Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average
Yahoo Finance ·
- Canaccord Genuity Keeps Their Buy Rating on ADMA Biologics (ADMA)
The Globe and Mail ·
- Q3 Earnings Beat Might Change The Case For ADMA Biologics Stock
Yahoo Finance ·
- Form 144 ADMA BIOLOGICS For: 5 November By Investing.com
Investing.com Nigeria ·
- ADMA Biologics CEO Adam Grossman sells $1.76M in shares
Investing.com ·
- A director at ADMA Biologics (ADMA) lists 189,000 shares worth $1.98M for sale.
Stock Titan ·
Adma Biologics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $510.2M | $426.5M | $258.2M | $154.1M |
| Net income | $146.9M | $197.7M | -$28.2M | -$65.9M |
| Diluted EPS | $0.60 | $0.81 | $-0.13 | $-0.33 |
| Total assets (year end) | $624.2M | $488.7M | $329.2M | $348.5M |
| Cash and equivalents (year end) | $87.6M | $103.1M | $51.4M | $86.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Adma Biologics, Inc.
- Ticker
- ADMA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Ramsey, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1368514
- Former names
- R&R ACQUISITION VI, INC
Frequently asked questions
What exchange is Adma Biologics, Inc. listed on?
Adma Biologics, Inc. trades on the Nasdaq under the ticker symbol ADMA.
What industry is Adma Biologics, Inc. in?
Adma Biologics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Adma Biologics, Inc. headquartered?
Adma Biologics, Inc.'s business address on file with the SEC is in Ramsey, NJ.
When does Adma Biologics, Inc.'s fiscal year end?
Adma Biologics, Inc.'s fiscal year ends on December 31.
How much revenue did Adma Biologics, Inc. report?
Adma Biologics, Inc. reported $510.2M in revenue for calendar year 2025, according to its SEC filings.